Xponance’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $360K | Sell |
3,663
-72
| -2% | -$7.08K | ﹤0.01% | 1068 |
|
2025
Q1 | $346K | Sell |
3,735
-614
| -14% | -$56.9K | ﹤0.01% | 1049 |
|
2024
Q4 | $395K | Buy |
4,349
+148
| +4% | +$13.4K | ﹤0.01% | 1027 |
|
2024
Q3 | $405K | Buy |
4,201
+49
| +1% | +$4.73K | ﹤0.01% | 1003 |
|
2024
Q2 | $381K | Sell |
4,152
-988
| -19% | -$90.7K | ﹤0.01% | 984 |
|
2024
Q1 | $474K | Buy |
5,140
+686
| +15% | +$63.2K | 0.01% | 956 |
|
2023
Q4 | $423K | Buy |
4,454
+378
| +9% | +$35.9K | 0.01% | 986 |
|
2023
Q3 | $381K | Buy |
4,076
+125
| +3% | +$11.7K | 0.01% | 979 |
|
2023
Q2 | $361K | Sell |
3,951
-349
| -8% | -$31.9K | ﹤0.01% | 999 |
|
2023
Q1 | $316K | Buy |
4,300
+43
| +1% | +$3.16K | ﹤0.01% | 1031 |
|
2022
Q4 | $356K | Buy |
4,257
+448
| +12% | +$37.4K | 0.01% | 1000 |
|
2022
Q3 | $369K | Sell |
3,809
-68
| -2% | -$6.59K | 0.01% | 941 |
|
2022
Q2 | $408K | Sell |
3,877
-2,593
| -40% | -$273K | 0.01% | 935 |
|
2022
Q1 | $1.12M | Sell |
6,470
-25
| -0.4% | -$4.31K | 0.02% | 553 |
|
2021
Q4 | $1.05M | Sell |
6,495
-86
| -1% | -$13.9K | 0.02% | 587 |
|
2021
Q3 | $981K | Sell |
6,581
-95
| -1% | -$14.2K | 0.02% | 566 |
|
2021
Q2 | $1.64M | Sell |
6,676
-71
| -1% | -$17.4K | 0.03% | 413 |
|
2021
Q1 | $1.79M | Hold |
6,747
| – | – | 0.04% | 339 |
|
2020
Q4 | $1.98M | Buy |
6,747
+32
| +0.5% | +$9.39K | 0.04% | 320 |
|
2020
Q3 | $1.59M | Buy |
6,715
+537
| +9% | +$127K | 0.04% | 328 |
|
2020
Q2 | $1.23M | Buy |
+6,178
| New | +$1.23M | 0.03% | 346 |
|